These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37309299)

  • 21. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S; Ho PC
    J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diphtheria toxoid nanoparticles improve learning and memory impairment in animal model of Alzheimer's disease.
    Heydari S; Hedayati Ch M; Saadat F; Abedinzade M; Nikokar I; Aboutaleb E; Khafri A; Mokarram AR
    Pharmacol Rep; 2020 Aug; 72(4):814-826. PubMed ID: 32048245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
    Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
    Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
    Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
    J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.
    Elnaggar YS; Etman SM; Abdelmonsif DA; Abdallah OY
    J Pharm Sci; 2015 Oct; 104(10):3544-56. PubMed ID: 26147711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished amyloid-β uptake by mouse microglia upon treatment with quantum dots, silver or cerium oxide nanoparticles: Nanoparticles and amyloid-β uptake by microglia.
    Sikorska K; Grądzka I; Sochanowicz B; Presz A; Męczyńska-Wielgosz S; Brzóska K; Kruszewski MK
    Hum Exp Toxicol; 2020 Feb; 39(2):147-158. PubMed ID: 31601117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model.
    Wahba SM; Darwish AS; Kamal SM
    Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():151-63. PubMed ID: 27157738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan mediated layer-by-layer assembly based graphene oxide decorated surface plasmon resonance biosensor for highly sensitive detection of β-amyloid.
    Nangare S; Patil P
    Int J Biol Macromol; 2022 Aug; 214():568-582. PubMed ID: 35752342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
    Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Tak K; Sharma R; Dave V; Jain S; Sharma S
    ACS Chem Neurosci; 2020 Nov; 11(22):3741-3748. PubMed ID: 33119989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation.
    Guo X; Lie Q; Liu Y; Jia Z; Gong Y; Yuan X; Liu J
    ACS Appl Mater Interfaces; 2021 Jul; 13(26):30261-30273. PubMed ID: 34169710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer's Disease in a Rat Animal Model: Involvement of STIM Proteins.
    Sanati M; Khodagholi F; Aminyavari S; Ghasemi F; Gholami M; Kebriaeezadeh A; Sabzevari O; Hajipour MJ; Imani M; Mahmoudi M; Sharifzadeh M
    ACS Chem Neurosci; 2019 May; 10(5):2299-2309. PubMed ID: 30933476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graphene quantum dots (GQDs)-based nanomaterials for improving photodynamic therapy in cancer treatment.
    Fan HY; Yu XH; Wang K; Yin YJ; Tang YJ; Tang YL; Liang XH
    Eur J Med Chem; 2019 Nov; 182():111620. PubMed ID: 31470307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graphene quantum dots redefine nanobiomedicine.
    Henna TK; Pramod K
    Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110651. PubMed ID: 32204078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
    Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
    Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease.
    Wang K; Wang L; Chen L; Peng C; Luo B; Mo J; Chen W
    Drug Deliv; 2021 Dec; 28(1):580-593. PubMed ID: 33729067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microfluidic Nanoparticles for Drug Delivery.
    Liu Y; Yang G; Hui Y; Ranaweera S; Zhao CX
    Small; 2022 Sep; 18(36):e2106580. PubMed ID: 35396770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.